Stem Cell Therapy for
Alzheimer’s Disease
Alzheimer’s affects 55 million people worldwide — a number growing every 3 seconds. Emerging research shows that stem cell therapy for Alzheimer’s disease can slow neurodegeneration, reduce inflammation, and support cognitive recovery where conventional medicine falls short.
Advanced Neurological Protocol
Targeted Cellular Regeneration
-
Aims to mitigate progressive neurodegeneration and brain tissue inflammation.
-
Formulated to support systemic neural pathway repair and cellular signaling.
-
Customized clinical management protocols tailored to cognitive stages.
Understanding
Alzheimer’s Disease
Alzheimer’s disease is the most common and progressive form of dementia, accounting for 60–80% of all dementia diagnoses. Every 3 seconds, someone worldwide is diagnosed. It progressively impairs memory, thinking, behavior, and eventually the ability to carry out daily tasks.
The disease primarily targets the brain’s neurons—particularly those responsible for memory and cognition—causing them to malfunction and die. As the condition advances, widespread brain atrophy occurs, leading to severe cognitive and functional decline.
Currently, no conventional pharmaceutical has succeeded in reversing Alzheimer’s progression. This is why stem cell therapy for Alzheimer’s disease has emerged as one of the most actively researched frontiers in neuroscience.
Primary Drivers of Neurodegeneration
While the definitive cause remains complex, research focuses on four destructive mechanisms within cerebral tissue that stem cell protocols target to support repair.
Genetic Factors
Mutations in genes like APP, PSEN1, and PSEN2 increase amyloid production. The APOE-e4 allele is the most significant genetic risk factor for late-onset progression.
Neuroinflammation
Chronic brain inflammation activates microglia and astrocytes, triggering a destructive cascade of cytokines that accelerate tau protein misfolding.
Amyloid Plaques
Toxic amyloid beta plaques accumulate between neurons, completely disrupting synaptic signaling arrays and triggering cellular apoptosis.
Mass Synaptic Loss
Progressive destruction of synaptic connections—the communication bridges between neurons—leads directly to memory loss and behavioral decline.
Evolution of Symptoms Across Cognitive Stages
Alzheimer’s symptoms evolve through early, middle, and late stages. While initial signs may be subtle, they progress with increasing severity over time.
Early Intervention Matters
According to clinical data, stem cell treatments show the highest efficacy when initiated during early-to-mid stages of the disease, before widespread, irreversible neuronal death occurs.
Alzheimer’s Treatment
Alzheimer’s disease is the most common cause of dementia, and traditional treatments provide limited long-term results. Recent studies, including stem cell therapy Alzheimer’s clinical trials, suggest that regenerative medicine may offer new possibilities.
Mesenchymal Stem Cells (MSCs) Mechanism
Stem cell therapy for Alzheimer’s disease uses mesenchymal stem cells (MSCs) to support neuronal repair, reduce inflammation, and improve cognitive function.
Treatment of Alzheimer’s
with Stem Cells
Acetylcholine is a critical neurotransmitter at synapses, enabling neurons to communicate. In Alzheimer’s disease, this system deteriorates rapidly. Our stem cell therapy for Alzheimer’s introduces hUC-MSCs (Human Umbilical Cord Mesenchymal Stem Cells) that actively support and rebuild this pathway.
These specialized cells release the essential neurotrophic factor BDNF (Brain-Derived Neurotrophic Factor), which increases synapse density between neurons. Concurrently, they secrete ChAT (Choline Acetyltransferase), directly improving acetylcholine synthesis across the brain to preserve critical neural networks.
Due to their specialized homing mechanisms, these cells migrate directly to areas of injury in the brain, crossing the blood-brain barrier to reduce oxidative stress and prevent further cell death. Clinical data demonstrates that hUC-MSCs can develop into neuroblast precursor cells—early-stage neurons—providing a functional biological foundation for neural regeneration.
Secreted Growth Factors Supporting Cortical Regrowth
Intravenously injected stem cells safely cross the blood-brain barrier to deliver these critical factors directly to the affected cortex and grey matter without requiring immune suppression.
6 Ways Stem Cells Act Against Alzheimer’s
Anti-Inflammatory
Reduces pro-inflammatory neural cytokines and microglial over-activation that accelerates neuronal death.
Neuroprotective
Creates a regenerative microenvironment that reduces oxidative stress and actively supports surviving neurons.
Neural Regeneration
Stimulates neurogenesis, angiogenesis, and cell differentiation—helping rebuild damaged brain circuits.
Plaque Inhibition
Shown to suppress beta-amyloid plaque formation and help clear existing plaques from neural tissue.
Synaptic Support
Increases release of BDNF and ChAT to strengthen synaptic communication and improve signal transmission.
Vascular Health
Promotes angiogenesis, improving blood flow to oxygen-deprived brain regions critical for sustained cognition.
Treatment Protocol to Treat Alzheimer’s with Stem Cells
At Stem Cells Bio Clinic, we recommend hUC-MSCs for Alzheimer’s treatment. This 5-day precision protocol is administered under continuous clinical monitoring by our expert neurological team.
Day 1: Infusion of hUC-MSCs + Exosomes
Initial intravenous infusion of umbilical cord mesenchymal stem cells combined with regenerative exosomes to establish a neuroprotective environment.
Day 2: Antioxidant Therapy with Vitamin C
High-dose intravenous Vitamin C therapy to reduce oxidative stress, protect newly introduced stem cells, and enhance cellular uptake efficiency.
Benefits of hUC-MSC Therapy
Challenges in Treating Alzheimer’s Disease
Alzheimer’s disease involves diverse cellular dysfunction across large areas of the brain, making it uniquely complex to treat.
Stem cell therapy represents the most promising approach to slow disease progression, preserve function, and improve quality of life. Our therapy is personalized, with protocols adapted to each patient’s specific biomarkers.
How are Stem Cells Collected?
We focus on delicate, specialized techniques to collect from the donor’s umbilical cord and placenta with parental consent, following strict WHO ethical guidelines.
How are Stem Cells managed?
We primarily utilize an intravenous route, though intra-pulmonary routes are also available based on the donor’s condition.
All about Stem Cells Bio Clinic
Located in Costa Rica, our clinic features a professional team of doctors, nurses, and theatre staff specializing in stem cell treatments for osteoarthritis and other conditions. We provide cost-effective, intensive care.
Book Your Appointment TodayScientific References:
Liu XY, Yang LP, Zhao L. Stem cell therapy for Alzheimer’s. World J Stem Cells. 2020 Aug 26;12(8):787-802. doi: 10.4252/wjsc.v12.i8.787
Alzheimer’s Association. 2017 Alzheimer’s Disease Facts and Figures. Alzheimer’s Dement 2017;13:325-373.
Kang, Jae Myeong, et al. Stem Cell Therapy for Alzheimer’s Disease: A Review of Recent Clinical Trials. Jan 1 2016: 879 – 889.
Tang Jun, How close is the stem cell cure to Alzheimer’s disease: Future and Beyond? Neural Regen Res. 2012 Jan 5; 7(1): 66–71.
A. E. Hernández, E. García, “Mesenchymal Stem Cell Therapy for Alzheimer’s Disease,” Stem Cells International, vol. 2021, Article ID 7834421. https://doi.org/10.1155/2021/7834421
Thomas Duncan and Michael Valenzuela. Alzheimer’s disease, dementia, and stem cell therapy. Stem Cell Research & Therapy (2017) 8:111.
Han, F., Bi, J., Qiao, L., Arancio, O. (2020). Stem Cell Therapy for Alzheimer’s Disease. In: Han, F., Lu, P.(. (eds) Stem Cell-based Therapy for Neurodegenerative Diseases. Advances in Experimental Medicine and Biology, vol 1266. https://doi.org/10.1007/978-981-15-4370-8_4
Salloway S, et al. Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer’s disease. N Engl J Med. 2014;370:322–33.